Stock ACXP ACURX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Acurx Pharmaceuticals, Inc.

Equities

ACXP

US00510M1045

Market Closed - Nasdaq
Other stock markets
 21:00:00 27/06/2024 BST 		5-day change 1st Jan Change
2.31 USD +3.12% Intraday chart for Acurx Pharmaceuticals, Inc. +3.59% -39.69%
05-15 Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection CI
05-15 Transcript : Acurx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 15, 2024

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Acurx Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 15, 2024
Transcript : Acurx Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 18, 2024
Transcript : Acurx Pharmaceuticals, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 12:00 PM
Transcript : Acurx Pharmaceuticals, Inc., Q3 2023 Earnings Call, Nov 14, 2023
Transcript : Acurx Pharmaceuticals, Inc., Q2 2023 Earnings Call, Aug 14, 2023
Transcript : Acurx Pharmaceuticals, Inc., Q1 2023 Earnings Call, May 12, 2023
Transcript : Acurx Pharmaceuticals, Inc., Q4 2022 Earnings Call, Mar 16, 2023
Transcript : Acurx Pharmaceuticals, Inc., Q3 2022 Earnings Call, Nov 14, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACXP Stock
  4. News Acurx Pharmaceuticals, Inc.
  5. Transcripts